These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 14288531)

  • 21. [THE TREATMENT OF TUBERCULOSIS WITH 2ND LINE DRUGS].
    SCHWARTZ WS
    Sem Med; 1964 Mar; 124():523-34. PubMed ID: 14156390
    [No Abstract]   [Full Text] [Related]  

  • 22. [ANTIMICROBIAL TREATMENT OF TUBERCULOSIS WITH SUBSIDIARY DRUGS. 2ND LINE DRUGS].
    ACEVEDO RC; HERRERO JJ; PILHEU J; RODRIGUEZ E
    Sem Med; 1964 Mar; 124():534-43. PubMed ID: 14156391
    [No Abstract]   [Full Text] [Related]  

  • 23. [METHOD FOR EVALUATING ANTITUBERCULAR DRUGS BY THEIR DIFFUSION INTO DEEP CULTURES OF TUBERCLE BACILLI IN SEMISOLID AGAR MEDIA].
    OKAMOTO K; FUJINAGA R; YAMAUCHI H
    Kekkaku; 1963 Sep; 38():413-7. PubMed ID: 14130758
    [No Abstract]   [Full Text] [Related]  

  • 24. [ON THE PROBLEM OF CROSS RESISTANCE OF TUBERCLE BACTERIA TO STREPTOMYCIN, KANAMYCIN AND VIOMYCIN].
    SCHMIEDEL A; GERLOFF W
    Z Tuberk Erkr Thoraxorg; 1964 Feb; 121():210-6. PubMed ID: 14149630
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effectiveness of the drugs of streptomycin group in experimental studies on albino mice infected with Mycobacterium tuberculosis resistant to these drugs].
    Kozulitsyna TI; Kozlova NV
    Probl Tuberk; 1976 Sep; (9):70-4. PubMed ID: 64981
    [No Abstract]   [Full Text] [Related]  

  • 26. [In vitro antituberculous activity of lividomycin].
    Kobayashi F; Nagoya T; Eda J; Yoshimura Y
    Jpn J Antibiot; 1972 Dec; 25(6):360-6. PubMed ID: 4125073
    [No Abstract]   [Full Text] [Related]  

  • 27. Drug-resistance test for kanamycin and cross resistance problem in Mycobacterium tuberculosis with special reference to kanamycin, streptomycin, and viomycin.
    TSUKAMURA M
    J Antibiot (Tokyo); 1959 Jul; 12():189-91. PubMed ID: 13855139
    [No Abstract]   [Full Text] [Related]  

  • 28. [Antituberculous activity of capreomycin and cross resistance to kanamycin, capreomycin, and viomycin. 2. In vitro study of cross resistance to capreomycin, kanamycin and viomycin].
    Tanaka K; Saiga S
    Bull Chest Dis Res Inst Kyoto Univ; 1969 Sep; 3(1):44-51. PubMed ID: 5401219
    [No Abstract]   [Full Text] [Related]  

  • 29. [COMPARISON OF A DETERMINATION OF DRUG RESISTANCE USING 1 PER CENT OGAWA MEDIUM AND LOEWENSTEIN-JENSEN MEDIUM (EXAMINATION OF SPUTUM)].
    TSUKAMURA S
    Kekkaku; 1964 Feb; 39():60-3. PubMed ID: 14136876
    [No Abstract]   [Full Text] [Related]  

  • 30. SPUTUM CONVERSION IN CHRONIC TUBERCULOSIS WITH POLYRESISTANT BACILLI.
    NOVAK M; JANCIK E
    Acta Tuberc Pneumol Scand; 1964; 45():301-19. PubMed ID: 14234473
    [No Abstract]   [Full Text] [Related]  

  • 31. [The degree of cross-resistance to kanamycin (KM) of tubercle bacilli resistant to capreomycin (CPM), and the degree of cross-resistance to KM and CPM of tubercle bacilli resistant to viomycin (VM) (author's transl)].
    Inagake H; Yamadori H; Inoue N; Mabuchi H; Ikeda N; Maekawa N
    Kekkaku; 1980 Jul; 55(7):323-30. PubMed ID: 6162994
    [No Abstract]   [Full Text] [Related]  

  • 32. [ON THE PROBLEM OF ANTIMYCOBACTERIAL EFFECT AND CROSS RESISTANCE OF CAPREOMYCIN].
    TRNKA L; KUSKA J; HAVEL A
    Prax Pneumol; 1964 Dec; 18():798-802. PubMed ID: 14335595
    [No Abstract]   [Full Text] [Related]  

  • 33. [ON THE INDICATIONS AND DOSAGE OF ETHIONAMIDE. DATA FROM LABORATORY EXPERIMENTATION].
    RIST N
    G Ital Chemioter; 1963; 10():83-6. PubMed ID: 14074254
    [No Abstract]   [Full Text] [Related]  

  • 34. [BACTERIAL RESISTANCE TO SUBSIDIARY ANTITUBERCULAR DRUGS].
    REY JC; CETRANGOLO A; DUBRA FA
    Medicina (B Aires); 1964; 24():273-6. PubMed ID: 14216722
    [No Abstract]   [Full Text] [Related]  

  • 35. [Antituberculous activity of capreomycin and cross resistance to kanamycin, capreomycin and viomycin. 1. In vitro effects of capreomycin on Mycobacterium and the survival of tuberculous mice treated with capreomycin].
    Tanaka K; Saiga S
    Bull Chest Dis Res Inst Kyoto Univ; 1969 Sep; 3(1):36-43. PubMed ID: 5401218
    [No Abstract]   [Full Text] [Related]  

  • 36. [PROBLEMS OF THE RESISTANCE OF MYCOBACTERIUM TUBERCULOSIS TO SNTITUBERCULAR AGENTS].
    KITAMOTO O; FUKUHARA T
    J Antibiot B; 1964 Jun; 17():112-6. PubMed ID: 14201522
    [No Abstract]   [Full Text] [Related]  

  • 37. [SOME DATA ON THE CHEMOTHERAPEUTIC PROPERTIES OF FLORIMYCIN (VIOMYCIN)].
    VASILENKO OS; BEREZINA EK
    Antibiotiki; 1963 Oct; 8():905-10. PubMed ID: 14136418
    [No Abstract]   [Full Text] [Related]  

  • 38. [Experimental and clinical study test of capreomycin].
    Kozlova NV; Dzhumaev B; Stepanian ES; Kaminskaia GO
    Antibiotiki; 1976 Jul; 21(7):650-4. PubMed ID: 60080
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cross resistance of Mycobacterium tuberculosis to streptomycin, kanamycin and viomycin].
    Makarevich NM; Mkrtchian SV; Afanas'eva IuP
    Antibiotiki; 1970 Apr; 15(4):345-51. PubMed ID: 4321321
    [No Abstract]   [Full Text] [Related]  

  • 40. Some experimental aspects of cross-resistance between capreomycin and viomycin.
    Algeorge G; Petre A
    Antibiot Chemother; 1970; 16():32-5. PubMed ID: 4108892
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.